Professional
Added to YB: 2024-10-11
Pitch date: 2024-10-10
CVS [bullish]
CVS Health Corporation
+24.8%
current return
Author Info
No bio for this author
Company Info
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments.
Market Cap
$77.0B
Pitch Price
$63.64
Price Target
82.00 (+3%)
Dividend
4.37%
EV/EBITDA
8.60
P/E
14.51
EV/Sales
0.39
Sector
Health Care Providers and Services
Category
turnaround
Barclays Raises CVS Health Price Target to $82
CVS (analyst upgrade): Barclays upgrades to Overweight, PT $82 (+24%). Sees margin recovery: Medicare improvement 100-200bps, $2B cost savings, retail share gains, CostVantage upside. 2026 EPS est. $8.77. 9.5x target multiple, 1-turn discount to SOTP. Analyst: Andrew Mok.
Read full article (1 min)